Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Vida Clinical Studies, LLC
Location: 3815 Pelham Street, Suite 4, Dearborn, MI 48124
Lead Doctor: Dr. Talal Khader
IRB Committee: This study has been reviewed and approved by IntegReview Institutional Review Board

Background

Preventive care is essential for those in the healthcare industry. There is a greater need for effective therapies to prevent  Viral Respiratory Infections (VRI),  especially in situations involving worldwide outbreaks. VRIs are a critical health concern due to the complications it presents.  COVID-19  (caused by  SARS-CoV-2)  is circulating around the globe and is posing a significant risk to healthcare workers. 

There is an urgent need for COVID-19 preventive care treatment. This study aims to investigate the effectiveness of a potential oral preventive care medication for COVID-19. 

Interested participants must be at least 18 years old and at risk of contracting COVID-19 due to the nature of their work. Participants must be able to attend the 4 study visits at the research site as well as comply with other study requirements for over 12 weeks. This study presents compensation for eligible participants. 

Why Participate? 

• You may gain possible protection from viral infections such as COVID-19.
• You may help advance preventive care from viral infections that may help others in the future.   
• You will be compensated up to $200 for participating in this study.
• You will contribute valuable information that may advance research for healthcare workers.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Healthcare workers aged 18 years old or older. 
  • Please note: A healthcare worker is defined as any of the following:
    • Provides healthcare services to patients 
    • Is in a situation that has close contact (within 6 feet) with patients 
    • Full-time employee (average of ≥ 24 hrs/week) in a high risk of contact such as the Emergency Department, Intensive Care Unit, COVID-specific Care Unit, Walk-in Clinic, Paramedic/First Responder
• Able to attend 4 study visits at the research site as well as comply with the following study requirements for over 12 weeks:
  • Must be able to take the study medication as well as a B complex vitamin twice a day as directed by the study team
  • Must be able to complete electronic diary (e-diary) entries  

Please note:

Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:

• The research site does not treat COVID-19 patients and/or suspected COVID-19 patients.
• The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
• Hand sanitizers are available at the research site.
• The research staff adheres to strict hygienic practices as well as other safety measures to prevent the spread of COVID-19. 
• Interested participants will not be left waiting for a long period of time and will be quickly attended to. 
• Parking is available at the research site.
• The study team encourages the use of personal vehicles, taxi or rideshare services rather than public transit. 
• The research site/institution is taking all precautionary measures to ensure the safety of the study participants.